デフォルト表紙
市場調査レポート
商品コード
1732851

放射線治療市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、エンドユーザー別、地域別、競合別、2020-2030年

Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type, By Application, By End-User, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 183 Pages
納期
2～3営業日
カスタマイズ可能
放射線治療市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、エンドユーザー別、地域別、競合別、2020-2030年
出版日: 2025年05月23日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

放射線治療の世界市場は、2024年に65億4,000万米ドルと評価され、2030年には106億8,000万米ドルに達すると予測され、予測期間中のCAGRは8.52%で拡大すると予測されています。

放射線治療は、電離放射線を用いてがん細胞を除去または縮小し、疾患の進行を管理するがん治療の要であり続けています。世界のがん罹患率の増加と非侵襲的治療ソリューションへの注目の高まりにより、放射線治療は力強い成長を遂げています。IMRT、SBRT、陽子線治療のような先進技術の採用は、より高い精度と少ない副作用を提供し、治療の展望を変えています。さらに、AI、リアルタイムイメージング、放射線手術技術の統合は、治療結果と業務効率を高めています。効果的な腫瘍学治療を重視する世界のヘルスケアエコシステムは、個別化された標的治療への需要の高まりと相まって、放射線治療市場の拡大を牽引し続けています。

市場概要
予測期間 2026-2030
市場規模：2024年 65億4,000万米ドル
市場規模：2030年 106億8,000万米ドル
CAGR：2025年～2030年 8.52%
急成長セグメント 病院
最大市場 北米

市場促進要因

技術の進歩

主な市場課題

コストとアクセシビリティの障壁

主な市場動向

高度な放射線照射技術

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の放射線治療市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 種類別（外照射療法、内照射療法、全身放射線療法）
    • 用途別（皮膚がん・口唇がん、乳がん、前立腺がん、子宮頸がん、肺がん、その他）
    • エンドユーザー別（病院、調査機関、外来、放射線治療センター）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米の放射線治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の放射線治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン

第8章 アジア太平洋地域の放射線治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の放射線治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの放射線治療市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 世界の放射線治療市場：SWOT分析

第14章 競合情勢

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler（BEBIG Medical）
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN（PMB）

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 16287

The Global Radiotherapy Market was valued at USD 6.54 Billion in 2024 and is projected to reach USD 10.68 Billion by 2030, expanding at a CAGR of 8.52% during the forecast period. Radiotherapy remains a cornerstone in cancer treatment, employing ionizing radiation to eliminate or shrink cancer cells and manage disease progression. With the increasing global incidence of cancer and the rising focus on non-invasive therapeutic solutions, radiotherapy is witnessing robust growth. The adoption of advanced technologies like IMRT, SBRT, and proton therapy is transforming the treatment landscape, offering higher precision and fewer side effects. Additionally, the integration of AI, real-time imaging, and radiosurgery techniques is enhancing treatment outcomes and operational efficiency. The global healthcare ecosystem's emphasis on effective oncology care, coupled with the growing demand for personalized and targeted treatments, continues to drive the expansion of the radiotherapy market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.54 Billion
Market Size 2030USD 10.68 Billion
CAGR 2025-20308.52%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Ongoing technological innovations have significantly fueled the growth of the Global Radiotherapy Market. The emergence of advanced techniques like Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), and Proton Therapy has revolutionized cancer care by enabling highly accurate targeting of tumors while preserving surrounding healthy tissue. This precision leads to improved outcomes and fewer adverse effects, making radiotherapy a preferred choice. Artificial Intelligence (AI) and Machine Learning (ML) are increasingly integrated into treatment planning, enhancing dose optimization and patient response prediction. Image-Guided Radiotherapy (IGRT) further ensures real-time monitoring during treatment, improving targeting accuracy. Additionally, the development of Radiosurgery and Stereotactic Radiosurgery (SRS) allows for high-dose, single-session treatments for small tumors, offering patients convenience and reduced treatment durations.

Key Market Challenges

Cost and Accessibility Barriers

One of the major barriers in the radiotherapy market is the high cost of implementation. Advanced radiotherapy systems, such as linear accelerators and proton therapy units, demand substantial capital investment, which can be a major hurdle for healthcare providers, especially in under-resourced regions. Beyond the purchase, ongoing maintenance, staff training, and operational expenses place additional financial pressure on facilities. Disparities in access are also a concern, with rural and low-income areas often lacking sufficient infrastructure for radiotherapy services. These challenges contribute to unequal access to advanced cancer care, limiting the market's reach and slowing the pace of widespread adoption despite growing demand.

Key Market Trends

Advanced Radiation Delivery Techniques

The evolution of advanced radiation delivery methods is reshaping the radiotherapy landscape. Techniques such as IMRT allow for modulation of radiation intensity to different areas of the tumor, minimizing impact on nearby healthy tissues and improving treatment precision. Proton therapy offers an even more targeted approach, as protons release energy directly at the tumor site, reducing collateral damage. Additionally, hypofractionation-delivering higher doses over fewer sessions-is gaining popularity for its convenience and efficiency. Stereotactic Radiosurgery (SRS), a form of hypofractionation, is increasingly used for treating small brain and body tumors. These innovations align with the growing demand for personalized treatment strategies that prioritize both efficacy and patient quality of life.

Key Market Players

  • Canon Medical Systems Corporation
  • GE Healthcare
  • Elekta
  • ViewRay Technologies, Inc.
  • Mevion Medical Systems
  • Eckert & Ziegler (BEBIG Medical)
  • Siemens Healthineers AG
  • Accuray Incorporated
  • Isoray Inc.
  • Hitachi, Ltd.
  • ALCEN (PMB)

Report Scope:

In this report, the Global Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Radiotherapy Market, By Type:

  • External Beam Radiation Therapy
  • Internal Radiation Therapy
  • Systemic Radiation Therapy

Radiotherapy Market, By Application:

  • Skin & Lip Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Radiotherapy Market, By End-User:

  • Hospitals
  • Research Institutes
  • Ambulatory and Radiotherapy Centers

Radiotherapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Radiotherapy Market.

Available Customizations:

Global Radiotherapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Radiotherapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy)
    • 5.2.2. By Application (Skin & Lip Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Others)
    • 5.2.3. By End-User (Hospitals, Research Institutes, Ambulatory and Radiotherapy Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Radiotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Radiotherapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Radiotherapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Radiotherapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-User

7. Europe Radiotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End-User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Radiotherapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-User
    • 7.3.2. United Kingdom Radiotherapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-User
    • 7.3.3. Italy Radiotherapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-User
    • 7.3.4. France Radiotherapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Radiotherapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-User

8. Asia-Pacific Radiotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Radiotherapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Radiotherapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Radiotherapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Radiotherapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Radiotherapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-User

9. South America Radiotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End-User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Radiotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-User
    • 9.3.2. Argentina Radiotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-User
    • 9.3.3. Colombia Radiotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-User

10. Middle East and Africa Radiotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End-User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Radiotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-User
    • 10.3.2. Saudi Arabia Radiotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-User
    • 10.3.3. UAE Radiotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Radiotherapy Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Canon Medical Systems Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. GE Healthcare
  • 14.3. Elekta
  • 14.4. ViewRay Technologies, Inc.
  • 14.5. Mevion Medical Systems
  • 14.6. Eckert & Ziegler (BEBIG Medical)
  • 14.7. Siemens Healthineers AG
  • 14.8. Accuray Incorporated
  • 14.9. Isoray Inc.
  • 14.10. Hitachi, Ltd.
  • 14.11. ALCEN (PMB)

15. Strategic Recommendations

16. About Us & Disclaimer